Italia markets closed

BMY Aug 2024 50.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,05000,0000 (0,00%)
In data: 09:56AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0500
ApertoN/D
Denaro0,0100
Domanda0,1900
Prezzo d'esercizio50,00
Scadenza2024-08-02
Min-Max giorno0,0500 - 0,0500
Contratto - Min-MaxN/D
VolumeN/D
Open Interest1
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri